Ascendis Pharma A (ASND) Return on Equity [ROE] (2015 - 2026)
Ascendis Pharma A (ASND) posted Return on Equity [ROE] of 77.38% for the quarter ended Jun 30, 2026, down 227.76 percentage points from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For the year ended Dec 31, 2023, Ascendis Pharma A's Return on Equity [ROE] came in at -868.31%, down 772.90 percentage points from the prior year.
- Annual Return on Equity [ROE] shows a five-year change of -834.31 percentage points (years ended Dec 2018 to Dec 2023).
- In prior years, Ascendis Pharma A's Return on Equity [ROE] was -95.41% in the year ended Dec 31, 2022 (-51.77 pp), -43.64% in the year ended Dec 31, 2021 (+16.51 pp), -60.15% in the year ended Dec 31, 2020 (-24.49 pp) and -35.66% in the year ended Dec 31, 2019 (-1.65 pp).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Return on Equity [ROE] since the quarter ended Jun 30, 2023.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was the quarter ended Dec 31, 2021, with a gain of 4.12 percentage points; the weakest was the quarter ended Jun 30, 2023, with a drop of 443.24 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 77.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.38% |
| Mar 31, 2026 | 305.14% |
| Jun 30, 2023 | -506.46% |
| Mar 31, 2023 | -262.32% |
| Dec 31, 2022 | -168.40% |
| Sep 30, 2022 | -94.09% |
| Jun 30, 2022 | -63.22% |
| Mar 31, 2022 | -58.75% |
| Dec 31, 2021 | -41.57% |
| Sep 30, 2021 | -49.81% |
| Jun 30, 2021 | -60.73% |
| Mar 31, 2021 | -49.60% |
| Dec 31, 2020 | -45.69% |
| Sep 30, 2020 | -49.55% |
| Jun 30, 2020 | -51.50% |
| Mar 31, 2020 | -39.94% |
| Dec 31, 2019 | -34.95% |
| Sep 30, 2019 | -25.65% |
| Jun 30, 2019 | -25.83% |
| Mar 31, 2019 | -22.13% |
API Access
Ascendis Pharma A Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();